Search Answers
Search Crossword Answers
Stupor following damage - no cure primarily for malignant tumour (7) Crossword Clue
Here is the answer for the crossword clue Stupor following damage - no cure primarily for malignant tumour (7) . We have found 40 possible answers for this clue in our database. Among them, one solution stands out with a 98% match which has a length of 7 letters. We think the likely answer to this clue is SARCOMA.
Crossword Answer For Stupor following damage - no cure primarily for malignant tumour (7):
You can click on thetiles to reveal letter by letter before uncovering the full solution.
40 Potential Answers:
| Rank | Answer | Length | Source | Date |
|---|---|---|---|---|
| 98% | SARCOMA Stupor following damage - no cure primarily for malignant tumour (7) | (7) | ||
| 5% | EVIL Malign | (4) | The Telegraph Quick | Sep 23, 2025 |
| 4% | MAR Damage | (3) | Commuter | Sep 24, 2025 |
| 4% | HARM Damage | (4) | TV | Sep 21, 2025 |
| 4% | ATEINTO Damaged by erosion | (7) | Premier Sunday | Sep 21, 2025 |
| 4% | EROSION Coastal damage | (7) | Puzzler Backwords | Sep 20, 2025 |
| 4% | HAM Cured breakfast meat | (3) | ||
| 4% | ECRU Color that's an anagram of "cure" | (4) | Universal | Sep 15, 2025 |
| 4% | HEAL Cure | (4) | The Telegraph Quick | Sep 11, 2025 |
| 4% | LOX Cured salmon | (3) | USA Today | Sep 11, 2025 |
Fresh Clues From Recent Puzzles
Your Crossword Clues FAQ Guide
We found 40 solutions for Stupor following damage - no cure primarily for malignant tumour (7). The top solutions are determined by popularity, ratings and frequency of searches. The most likely answer for the clue is SARCOMA.
With crossword-solver.io you will find 40 solutions. We use historic puzzles to find the best matches for your question. We add many new clues on a daily basis.
With our crossword solver search engine you have access to over 7 million clues. You can narrow down the possible answers by specifying the number of letters it contains. We found more than 40 answers for Stupor following damage - no cure primarily for malignant tumour (7).